AMANDA MCCONNELL: Open Payments
NPI 1801155775 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 49 payments from 17 companies in 2025. Trend: 2023 $1,253 · 2024 $1,879 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 10 | $219 |
| Regeneron Pharmaceuticals, Inc. | 1 | $149 |
| Janssen Biotech, Inc. | 6 | $104 |
| Incyte Corporation | 4 | $97 |
| Amgen Inc. | 6 | $95 |
| ABBVIE INC. | 4 | $84 |
| PFIZER INC. | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Novo Nordisk Inc | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
Products named: Zoryve, LIBTAYO, TREMFYA, OPZELURA, Otezla, CIBINQO, RINVOQ, Ozempic.
Industry payments across CA — which companies pay providers there.
